KRAS somatic mutations are found in 30–40% of colorectal cancer (CRC). Seven mutations in codons 12 and 13 of KRAS (95% of the observed human mutations) preclude the efficacy of anti-EGFR therapy for the treatment of CRC.
Sample Type - Others/Any sample
Reporting Time - Please Call Customer care
Prerequisites - No special preparation required
Price - ₹9080/-
Add to cart Go Home